Abbvie Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 02, 2020 / 07:40PM GMT
Joshua Elliott Schimmer - Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI biotech team and pleased to welcome from AbbVie, we have Mike Severino, Vice Chairman and President; Rob Michael, Executive Vice President and Chief Financial Officer; Jeff Stewart, President of U.S. Commercial Operations. Wonderful to have you, gentlemen, here. Thanks for joining us.

Questions and Answers:

Joshua Elliott Schimmer - Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

Looking at some of the item script trajectories for RINVOQ and SKYRIZI, it's hard to tell we're in a pandemic. Really, incredible launches. Maybe you can talk and kick things off talking a little bit about the pushes and pulls of these launches in a pandemic and where the headwinds are and tailwinds.

Michael E. Severino - AbbVie Inc. - Vice Chairman & President

Sure. I'll start, and then Rob and Jeff may want to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot